Nuance Medical completed the acquisition of BIOCORNEUM, a state-of-the-art silicone gel scar treatment brand, previously owned by Sientra. Effective immediately, BIOCORNEUM will become a part of the Biodermis portfolio, Nuance Medical's brand specializing in silicone scar management products. This strategic move enhances Biodermis' commitment to providing top-tier skin care solutions to healthcare professionals.
CARLSBAD, Calif., April 18, 2024 /PRNewswire-PRWeb/ -- Nuance Medical, a leading designer, developer, and marketer of branded and private label medical products, announced today the successful acquisition of BIOCORNEUM, a state-of-the-art silicone gel scar treatment brand, previously owned by Sientra. Effective immediately, BIOCORNEUM will become a part of the Biodermis portfolio, Nuance Medical's brand specializing in silicone scar management products. This strategic move enhances Biodermis' commitment to providing top-tier skin care solutions to healthcare professionals.
Recognized for over 30 years of innovation and effectiveness in scar management, Biodermis has been at the forefront of medical-grade silicone treatments for over three decades. Known for its dedication to quality and innovation, Biodermis is a trusted name among healthcare providers for effective, non-invasive scar management solutions.
With the addition of BIOCORNEUM to Biodermis' extensive line of scar management solutions, it ensures that the acclaimed properties of BIOCORNEUM will continue under a brand that profoundly understands the needs and expectations of healthcare professionals and their patients.
"Bringing BIOCORNEUM into the Biodermis family marks a significant step in our journey to lead with innovative and impactful treatments in scar management," said Mark Steele, President of Nuance Medical. "This acquisition integrates BIOCORNEUM's strong presence in the professional healthcare sector with Biodermis' comprehensive range of silicone scar management products. We are excited about the combined capabilities this brings and the enhanced benefits it offers to our healthcare partners and their patients."
In order to facilitate a smooth transition and continuous support, BIOCORNEUM customers are asked to contact Biodermis directly for placing orders or inquiries at 800.322.3729 or via email at [email protected]. In addition, a dedicated webpage with frequently asked questions for BIOCORNEUM customers can be found at: https://www.biodermis.com/pages/biocorneum-customer-faqs.
For further information on Biodermis, visit: https://www.biodermis.com/.
About Biodermis
Biodermis, a brand under Nuance Medical, has been at the forefront of medical-grade silicone treatments for over three decades. Known for its dedication to quality and innovation, Biodermis is a trusted name among healthcare providers for effective, non-invasive scar management solutions.
About Nuance Medical
Headquartered in Carlsbad, California, Nuance Medical is a leading designer, developer, and marketer of branded and private label medical products. The company, formed in 2013, develops innovative products for underserved, niche markets in the healthcare sector. Nuance's capabilities include product development, sales and marketing expertise.
Media Contact
Natalie Mikolich, Nuance Medical, 5614144047, [email protected], https://www.nuancemedical.com/
SOURCE Nuance Medical
Share this article